A potential candidate for the COVID-19 vaccine that is being developed by the global healthcare company Johnson & Johnson (J&J) has prevented severe illness in a group of golden hamsters as announced by the company on Thursday (3rd September). The vaccine also happened to prevent weight loss, pneumonia, and even death in the small group of Syrian golden hamsters.
The results of the research show that the vaccine drew out antibodies in the vaccinated hamsters which as believed by the researchers is required to build up the immune system. The research also shows that while the vaccinated hamsters didn’t fall prey to any sort of severe illness like mortality or pneumonia, these hamsters also lost lesser weight in comparison to the unvaccinated ones.
The results of the same have been published in the medical journal Nature Medicine on Thursday itself.
Paul Stoffels, the Chief Scientific Officer at J&J states: “This pre-clinical study further validates our confidence in our SARS-CoV-2 vaccine candidate”.
Paul also happened to state that the company with a vision of providing global access to the vaccine is extremely committed towards its manufacturing and distribution. The company further mentioned that they plan on entering the phase 3 trials by this month.
The researchers in J&J gave a single dose of the COVID-19 vaccine to the rodents and after a period of four weeks, they were exposed to the virus. Though these promising results do not necessarily indicate similar protection in humans, however, the findings from the research are important since the virus tends to turn into a severe disease in some humans.
As of now, J&J stands amongst those several companies that are working towards developing a COVID-19 vaccine. The company is expected to enter into the third phase of trials with a group of 60,000 people. This is by far the largest trial testing of a vaccine and the participants of the same shall be picked randomly.
Hope you enjoy the article “COVID-19 VACCINE: J&J’S VACCINE PREVENTS SEVERE ILLNESS IN HAMSTERS” stay tuned for more updates.